Hepatitis B vaccine - Panacea Biotec

Drug Profile

Hepatitis B vaccine - Panacea Biotec

Alternative Names: Enivac HB; Enivac HB Safsy; EnivacHB

Latest Information Update: 24 Feb 2014

Price : $50

At a glance

  • Originator Panacea Biotec
  • Class Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis B

Most Recent Events

  • 01 Aug 2006 Launched for Hepatitis B in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top